Covaxin is the first Covid-19 vaccine to be tested in the 2-6 years age group. The made-in-India vaccine will be administered in two doses, with a gap of 28 days in between the first and second dose.
Read More Covaxin vaccine gets emergency use approval for kids
ZyCoV-D is the world’s first plasmid (small rings of DNA) DNA vaccine. It uses a section of genetic material (DNA) from the virus.
Read More World’s First DNA based COVID Vaccine Got its Approval
On Saturday, the Government of India approved the single-dose vaccine of Johnson and Johnson for emergency use in India.
Read More Johnson and Johnson Single Dose Vaccine gets Emergency Use Approval in India
The Drugs Controller General of India (DCGI) has granted permission to Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country.
Read More India’s Cipla gets approval to import Moderna’s COVID-19 vaccine
On June 21st, India made its vaccination program free for all citizens. India’s vaccine, Covaxin, released the results of its third phase trials.
Read More India’s Vaccination and Vaccine Update
India became the second fastest country to give more than 1 crore (10 million) doses of COVID-19 vaccination in a span of 34 days.
Read More India’s Covid-19 Vaccination Program Update
India started supplying vaccines to neighboring countries Bangladesh and Nepal from 20th January 2021 under grant assistance.
Read More Supply of Indian manufactured vaccines to neighbouring and key partner countries
The first phase of vaccination against COVID -19 has started in India on January 16, 2020. It will cover estimated 3 crore healthcare workers and front-line workers first.
Read More Vaccination drive of India – Started Now